The Role of MicroRNAs in Hyperlipidemia: From Pathogenesis to Therapeutical Application

Hyperlipidemia is a common metabolic disorder with high morbidity and mortality, which brings heavy burden on social. Understanding its pathogenesis and finding its potential therapeutic targets are the focus of current research in this field. In recent years, an increasing number of studies have pr...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu Xiang, Li Mao, Mei-Ling Zuo, Gui-Lin Song, Li-Ming Tan, Zhong-Bao Yang
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2022/3101900
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849404997694914560
author Yu Xiang
Li Mao
Mei-Ling Zuo
Gui-Lin Song
Li-Ming Tan
Zhong-Bao Yang
author_facet Yu Xiang
Li Mao
Mei-Ling Zuo
Gui-Lin Song
Li-Ming Tan
Zhong-Bao Yang
author_sort Yu Xiang
collection DOAJ
description Hyperlipidemia is a common metabolic disorder with high morbidity and mortality, which brings heavy burden on social. Understanding its pathogenesis and finding its potential therapeutic targets are the focus of current research in this field. In recent years, an increasing number of studies have proved that miRNAs play vital roles in regulating lipid metabolism and were considered as promising therapeutic targets for hyperlipidemia and related diseases. It is demonstrated that miR-191, miR-222, miR-224, miR-27a, miR-378a-3p, miR-140-5p, miR-483, and miR-520d-5p were closely associated with the pathogenesis of hyperlipidemia. In this review, we provide brief overviews about advances in miRNAs in hyperlipidemia and its potential clinical application value.
format Article
id doaj-art-4948049c4bcb4fc8ac97e4b468211de2
institution Kabale University
issn 1466-1861
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-4948049c4bcb4fc8ac97e4b468211de22025-08-20T03:36:48ZengWileyMediators of Inflammation1466-18612022-01-01202210.1155/2022/3101900The Role of MicroRNAs in Hyperlipidemia: From Pathogenesis to Therapeutical ApplicationYu Xiang0Li Mao1Mei-Ling Zuo2Gui-Lin Song3Li-Ming Tan4Zhong-Bao Yang5The Affiliated Changsha Hospital of Hunan Normal UniversityDepartment of Basic MedicineThe Affiliated Changsha Hospital of Hunan Normal UniversityThe Affiliated Changsha Hospital of Hunan Normal UniversityThe Affiliated Changsha Hospital of Hunan Normal UniversityThe Affiliated Changsha Hospital of Hunan Normal UniversityHyperlipidemia is a common metabolic disorder with high morbidity and mortality, which brings heavy burden on social. Understanding its pathogenesis and finding its potential therapeutic targets are the focus of current research in this field. In recent years, an increasing number of studies have proved that miRNAs play vital roles in regulating lipid metabolism and were considered as promising therapeutic targets for hyperlipidemia and related diseases. It is demonstrated that miR-191, miR-222, miR-224, miR-27a, miR-378a-3p, miR-140-5p, miR-483, and miR-520d-5p were closely associated with the pathogenesis of hyperlipidemia. In this review, we provide brief overviews about advances in miRNAs in hyperlipidemia and its potential clinical application value.http://dx.doi.org/10.1155/2022/3101900
spellingShingle Yu Xiang
Li Mao
Mei-Ling Zuo
Gui-Lin Song
Li-Ming Tan
Zhong-Bao Yang
The Role of MicroRNAs in Hyperlipidemia: From Pathogenesis to Therapeutical Application
Mediators of Inflammation
title The Role of MicroRNAs in Hyperlipidemia: From Pathogenesis to Therapeutical Application
title_full The Role of MicroRNAs in Hyperlipidemia: From Pathogenesis to Therapeutical Application
title_fullStr The Role of MicroRNAs in Hyperlipidemia: From Pathogenesis to Therapeutical Application
title_full_unstemmed The Role of MicroRNAs in Hyperlipidemia: From Pathogenesis to Therapeutical Application
title_short The Role of MicroRNAs in Hyperlipidemia: From Pathogenesis to Therapeutical Application
title_sort role of micrornas in hyperlipidemia from pathogenesis to therapeutical application
url http://dx.doi.org/10.1155/2022/3101900
work_keys_str_mv AT yuxiang theroleofmicrornasinhyperlipidemiafrompathogenesistotherapeuticalapplication
AT limao theroleofmicrornasinhyperlipidemiafrompathogenesistotherapeuticalapplication
AT meilingzuo theroleofmicrornasinhyperlipidemiafrompathogenesistotherapeuticalapplication
AT guilinsong theroleofmicrornasinhyperlipidemiafrompathogenesistotherapeuticalapplication
AT limingtan theroleofmicrornasinhyperlipidemiafrompathogenesistotherapeuticalapplication
AT zhongbaoyang theroleofmicrornasinhyperlipidemiafrompathogenesistotherapeuticalapplication
AT yuxiang roleofmicrornasinhyperlipidemiafrompathogenesistotherapeuticalapplication
AT limao roleofmicrornasinhyperlipidemiafrompathogenesistotherapeuticalapplication
AT meilingzuo roleofmicrornasinhyperlipidemiafrompathogenesistotherapeuticalapplication
AT guilinsong roleofmicrornasinhyperlipidemiafrompathogenesistotherapeuticalapplication
AT limingtan roleofmicrornasinhyperlipidemiafrompathogenesistotherapeuticalapplication
AT zhongbaoyang roleofmicrornasinhyperlipidemiafrompathogenesistotherapeuticalapplication